Publications by authors named "Kelly Griffey"

Claim this Profile
I
In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders.
Linda M Rorick-Kehn, Bryan G Johnson, Karen M Knitowski, Craig R Salhoff, Jeffrey M Witkin, Kelly I Griffey

Psychopharmacology (Berl)· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(2S,1'S,2'R,3'R)-2-(2'-Carboxy-3'-hydroxymethylcyclopropyl) glycine is a highly potent group 2 and 3 metabotropic glutamate receptor agonist with oral activity.
Iván Collado, Concepción Pedregal, Ana Belén Bueno, Alicia Marcos, Rosario González, Kelly I Griffey

J Med Chem· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The anxiolytic action of mGlu2/3 receptor agonist, LY354740, in the fear-potentiated startle model in rats is mechanistically distinct from diazepam.
Joseph P Tizzano, Kelly I Griffey, Darryle D Schoepp

Pharmacol Biochem Behav· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of group I metabotropic glutamate receptor responses in vivo in rats by a new generation of carboxyphenylglycine-like amino acid antagonists.
Ann E Kingston, Kelly Griffey, Michael P Johnson, Mary-Jo Chamberlain, Gerald Kelly

Neurosci Lett· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis